These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis. Carter BJ; Flotte TR Curr Top Microbiol Immunol; 1996; 218():119-44. PubMed ID: 8794249 [No Abstract] [Full Text] [Related]
10. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347 [TBL] [Abstract][Full Text] [Related]
11. Laying the Foundation for Cystic Fibrosis Therapy: An Interview with Michael Boyle. Davies K Hum Gene Ther; 2020 Sep; 31(17-18):917-920. PubMed ID: 32924627 [No Abstract] [Full Text] [Related]
12. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401 [No Abstract] [Full Text] [Related]
16. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy. Guggino WB; Cebotaru L Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956 [TBL] [Abstract][Full Text] [Related]
17. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Wagner JA; Reynolds T; Moran ML; Moss RB; Wine JJ; Flotte TR; Gardner P Lancet; 1998 Jun; 351(9117):1702-3. PubMed ID: 9734891 [No Abstract] [Full Text] [Related]